Wilson Sonsini Goodrich & Rosati has advised Firefly Bio. Ropes & Gray has advised Johnson & Johnson. Johnson & Johnson (NYSE: JNJ) has announced the successful...
Johnson & Johnson Completes $1 Billion Acquisition of Firefly Bio
Ona Therapeutics Completes $86.6 Million Series B Financing
Wilson Sonsini Goodrich & Rosati has advised Ona Therapeutics. Ona Therapeutics, a biopharmaceutical company focused on pioneering antibody-drug conjugates (ADCs) for treatment-resistant cancers, has announced the...
Edgewise Therapeutics Sells Muscular Dystrophy Business and Sevasemten to Servier for up to $2.65 Billion
Wilson Sonsini Goodrich & Rosati has advised Edgewise Therapeutics on the transaction. McDermott Will & Schulte has advised Servier. White & Case has advised Servier on...
Lilly Acquires Centessa Pharmaceuticals for Up to $7.8 Billion to Bolster Neuroscience Portfolio
Kirkland & Ellis has advised Eli Lilly and Company. Goodwin Procter and Wilson Sonsini Goodrich & Rosati have advised Centessa Pharmaceuticals plc. Eli Lilly and Company...
Servier to Acquire Day One Biopharmaceuticals in $2.5 Billion Transaction
Baker McKenzie has advised Servier, and Fenwick & West has advised Day One Biopharmaceuticals. Wilson Sonsini Goodrich & Rosati advised Day One on IP matters related...
Day One Biopharmaceuticals to Acquire Mersana Therapeutics in Transaction Valued Up to $285 Million
Wilmer Cutler Pickering Hale and Dorr has advised Mersana Therapeutics. Fenwick & West has advised Day One Biopharmaceuticals. Wilson Sonsini Goodrich & Rosati advised Day One...
Edgewise Therapeutics’ $200 Million Common Stock Offering
Wilson Sonsini Goodrich & Rosati represented Edgewise Therapeutics on the transaction, and Cooley advised the underwriters for the offering. Edgewise Therapeutics, Inc. (NASDAQ: EWTX) (Edgewise), a...
Aeovian Pharmaceuticals’ $50 Million Series A Financing Round
Wilson Sonsini Goodrich & Rosati advised Aeovian Pharmaceuticals on patent matters in connection with the transaction. Aeovian Pharmaceuticals, a clinical-stage biopharmaceutical company, announced it has raised...
Genmab’s $1.8 Billion Acquisition of ProfoundBio
Cooley, Travers Thorp Alberga and Jun He Law Offices advised ProfoundBio and Wilson Sonsini Goodrich and Rosati advised ProfoundBio on patent matters related to the transaction,...
Edgewise Therapeutics’ $240 Million Common Stock Offering
Wilson Sonsini Goodrich & Rosati represented Edgewise Therapeutics on the transaction, and Cooley represented the underwriters. Edgewise Therapeutics, Inc. (“Edgewise”) (NASDAQ: EWTX) announced the pricing of an underwritten...
BigHat Biosciences’ Research Collaboration with AbbVie
Wilson Sonsini Goodrich & Rosati advised BigHat on the transaction. AbbVie Inc. and BigHat Biosciences announced a research collaboration to discover and develop next-generation therapeutic antibodies...
L Catterton’s $680 Million Acquisition of Thorne HealthTech
Kirkland & Ellis LLP is representing L Catterton, and Wilson Sonsini Goodrich & Rosati is representing Thorne HealthTech, Inc. in the transaction. Thorne HealthTech, Inc. (“Thorne”)...